I have a friend who wanted to know anything about a cancer treatment called B17 any info will surely be appreciated thank you Lynda
----- Original Message ----- From: Stuff To: [email protected] Sent: Wednesday, September 24, 2003 9:05 AM Subject: Re: CS>Cancer and CS ions Many thanks for this, Trem At 02:37 PM 9/23/2003 -0700, you wrote: Hi List, Here's some more interesting info I found by Robert O. Becker and the use of silver ions. He did some work with silver ions relating to cancer but never followed up. It could be that even if cancer is caused by virus that the cells can dedifferentiate back to normal cells by coming in contact with silver ions. In my opinion it would be a good idea to take CS on a daily basis to kill any cancer cells that may be growing inside us while we are unaware of them. It isn't until we can experience some symptom that we then discover we have a problem. Why not stop the cancer when it is small and before it gets to the size that we notice it. Trem Pages 164-166 Cross Currents By Dr. Robert O. Becker "In each case, the nonunions healed even faster than they would have if negative electrical currents had been used. In addition, the soft tissues and skin healed at the same extraordinary rate. The electrically generated silver ion was doing something more than killing bacteria-it was also causing major growth stimulation of tissues in the wound. When we finally tracked down exactly what was happening, we found that as human fibroblast cells (which are common throughout the body) were exposed to the electrically generated silver ions, they dedifferentiated. They were then able to multiply at a great rate, producing large numbers of primitive, embryonic cells in the wound even in patients over fifty years of age. These "uncommitted" cells were then able to differentiate into whatever cell types were needed to heal the wound. So what we were in fact doing was turning on regeneration in human tissues, which I had thought we would never be able to do. In our previous studies of regeneration, we had found that in human beings, only bone-marrow cells could dedifferentiate. Because there were so few such cells, we thought that any regeneration in human beings (other than fracture healing) was impossible. The dedifferentiation of the abundant fibroblast cells by electrically generated silver ions may provide us with the means to restore regeneration to human patients. While I was excited at this serendipitous discovery, my patients could have cared less how the wounds were healed. They were simply delighted at the fact that, at long last, a treatment had worked. Perhaps the most important moral in this story is that it demonstrates that no one can tell in advance what will happen in a scientific experiment. Electrochemical Therapy for Cancer Actually, this circuitous pathway led us back to one of our original aims, the control of cancer growth. If the electrically generated silver ion dedifferentiated normal human fibroblast cells, would it also dedifferentiate human cancer cells? If so, we would have a way to duplicate in human beings Dr. S. Meryl Rose's experiments with salamander cancers, in which dedifferentiated cancer cells redifferentiated as normal cells. A lack of funds, unfortunately, prevented us from completing this work. However, we did find that some human cancer cells in culture appeared to dedifferentiate when exposed to these silver ions. I also had a patient with a severe, chronic bone infection who had an associated cancer in the wound. He refused amputation, which would have been the treatment of choice, and insisted that I treat his infection with the silver technique. After three months, the infection was under control, and the cancer cells in the wound appeared to have changed back to normal. When I last heard from him, eight years after the treatment, he was still fine. It is important to realize that this is not simply an electrical effect, but the result of the combined action of the electrical voltage and the electrically generated silver ions. It is an electrochemical treatment. While we do not have firm evidence at this time, what probably happens is that the silver ion is shaped so as to connect with some receptor group on the surface of the cancer-cell membrane. After that connection is made, an electrical-charge transfer sends a signal to the nucleus of the cancer cell that activates the primitive-type genes, and the cell dedifferentiates. In that state it awaits instructions as to what it is to become. The process is exactly the same as that in Rose's experiments, except that in this case the dedifferentiation is caused by the unexpected action of the positive silver ions. This technique obviously requires more study before any clinical use can be made of its antitumor effect. However, it does appear to be a promising lead in an otherwise rather grim picture." Regards, Trem Williams [email protected]
